Skip to content

On the 16th July 2020 the Clinical Senate deliberated the questions:

What beneficial innovations/changes have occurred in specialty and patient pathways as a result of the response to COVID 19?
What has been the impact of these innovations/changes, what is needed to sustain them and what hasn’t worked so well?

Download the recommendations here

Agenda

Agenda 2020 07 16